ASA bans Instagram post for filler competition
The Advertising Standards Authority (ASA) has banned an Instagram post by Faces by AKJ Aesthetics promoting a dermal filler competition.
The Advertising Standards Authority (ASA) has banned an Instagram post by Faces by AKJ Aesthetics promoting a dermal filler competition.
The Advertising Standards Authority (ASA) has banned an Instagram post by Beauty Boutique Aesthetics after a complaint regarding misleading advertising and the advertisement of a prescription-only medicine.
The Aesthetic Medicine Congress (TAMC), in association with the British College of Aesthetic Medicine, will take place in Dubrovnik on October 12 and 13.
Global pharmaceutical company Allergan has manufactured the 100 millionth vial of botulinum toxin type A Botox, which the company has said is a ‘significant milestone in the history of the brand’.
Global pharmaceutical company Allergan is launching a website to support healthcare professionals working within medical aesthetics called Allergan Spark.
The Food and Drug Administration (FDA) has approved Jeuveau, a botulinum toxin type A, for the temporary improvement in the appearance of moderate to severe glabellar lines.
High street retailer Superdrug, which started offering a botulinum toxin and dermal filler service last year, has said that it will introduce tougher mental health checks for patients as a result of concerns voiced by the NHS.
IQ Resources, a sister company to IQ Verify, a UKAS accredited certification body has launched a new eLearning package titled the Botulinum Toxin and Dermal Filler Level 7 eLearning.
Practitioners outline how they communicate the benefits of offering a multi-treatment approach to patients How many times has a patient attended your clinic for a consultation and said ‘I want 0.5ml of lip filler please’ or ‘Can I have two …
Subscriber content
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
An examination of the literature and emerging indications by Mr Dalvi Humzah, Professor Andy Pickett and Anna Baker.
Subscriber content
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in